New OCABR vaccine guidelines to improve regulation efficiency

2026-05-07T11:31:00

DNA vaccine vial concept

Source:

One new guideline relevant to mRNA vaccines produced with LNPs and two revised guidelines for vaccines to treat infectious diseases.

Following its adoption on 1 May, the European Directorate for the Quality of Medicines & HealthCare (EDQM) has published a single guideline for mRNA vaccines produced with lipid nanoparticles (LNPs), supporting regulatory consistency and efficiency.

The new guideline establishes a harmonised framework for the co-ordinated, independent control of these EU-bound vaccines. Appliable products include

Already a member? Sign-in

Unlock

Driving innovation in pharma manufacturing

European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.

Become a member to continue reading

By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:

  • Unlimited access to industry intelligence that can make a difference to your business
  • A weekly newsletter keeping the most vital information at the front of your thinking
  • Exclusive invitations to powerful webinars and events featuring high profile experts
  • Access to deep-dive reports and analysis that reveal exciting new opportunities for business growth and transformation

Become a member